298 related articles for article (PubMed ID: 31387121)
1. The effect of menaquinone-7 supplementation on vascular calcification in patients with diabetes: a randomized, double-blind, placebo-controlled trial.
Zwakenberg SR; de Jong PA; Bartstra JW; van Asperen R; Westerink J; de Valk H; Slart RHJA; Luurtsema G; Wolterink JM; de Borst GJ; van Herwaarden JA; van de Ree MA; Schurgers LJ; van der Schouw YT; Beulens JWJ
Am J Clin Nutr; 2019 Oct; 110(4):883-890. PubMed ID: 31387121
[TBL] [Abstract][Full Text] [Related]
2. The effect of six-month oral vitamin K supplementation on calcification propensity time in individuals with type 2 diabetes mellitus: A post hoc analysis of a randomized, double-blind, placebo-controlled trial.
Meer R; Romero Prats ML; Vervloet MG; van der Schouw YT; de Jong PA; Beulens JWJ
Atherosclerosis; 2024 Jul; 394():117307. PubMed ID: 37852868
[TBL] [Abstract][Full Text] [Related]
3. The effect of vitamin K1 on arterial calcification activity in subjects with diabetes mellitus: a post hoc analysis of a double-blind, randomized, placebo-controlled trial.
Bellinge JW; Francis RJ; Lee SC; Bondonno NP; Sim M; Lewis JR; Watts GF; Schultz CJ
Am J Clin Nutr; 2022 Jan; 115(1):45-52. PubMed ID: 34637494
[TBL] [Abstract][Full Text] [Related]
4. Effect of vitamin K supplementation on serum calcification propensity and arterial stiffness in vitamin K-deficient kidney transplant recipients: A double-blind, randomized, placebo-controlled clinical trial.
Eelderink C; Kremer D; Riphagen IJ; Knobbe TJ; Schurgers LJ; Pasch A; Mulder DJ; Corpeleijn E; Navis G; Bakker SJL; de Borst MH; Te Velde-Keyzer CA
Am J Transplant; 2023 Apr; 23(4):520-530. PubMed ID: 36695702
[TBL] [Abstract][Full Text] [Related]
5. Menaquinone-7 Supplementation to Reduce Vascular Calcification in Patients with Coronary Artery Disease: Rationale and Study Protocol (VitaK-CAC Trial).
Vossen LM; Schurgers LJ; van Varik BJ; Kietselaer BL; Vermeer C; Meeder JG; Rahel BM; van Cauteren YJ; Hoffland GA; Rennenberg RJ; Reesink KD; de Leeuw PW; Kroon AA
Nutrients; 2015 Oct; 7(11):8905-15. PubMed ID: 26516910
[TBL] [Abstract][Full Text] [Related]
6. Vitamin K2 supplementation in haemodialysis patients: a randomized dose-finding study.
Caluwé R; Vandecasteele S; Van Vlem B; Vermeer C; De Vriese AS
Nephrol Dial Transplant; 2014 Jul; 29(7):1385-90. PubMed ID: 24285428
[TBL] [Abstract][Full Text] [Related]
7. Study protocol of the InterVitaminK trial: a Danish population-based randomised double-blinded placebo-controlled trial of the effects of vitamin K (menaquinone-7) supplementation on cardiovascular, metabolic and bone health.
Kampmann FB; Thysen SM; Nielsen CFB; Kofoed KF; Køber L; Pham MHC; Vaag A; Jørgensen NR; Petersen J; Jacobsen RK; Kårhus LL; Diederichsen A; Frimodt-Møller M; Linneberg A
BMJ Open; 2023 May; 13(5):e071885. PubMed ID: 37208133
[TBL] [Abstract][Full Text] [Related]
8. The effect of menaquinone-7 supplementation on dp-ucMGP, PIVKAII, inflammatory markers, and body composition in type 2 diabetes patients: a randomized clinical trial.
Karamzad N; Faraji E; Adeli S; Sullman MJM; Pourghassem Gargari B
Nutr Diabetes; 2022 Apr; 12(1):15. PubMed ID: 35365594
[TBL] [Abstract][Full Text] [Related]
9. Vitamin K supplementation and arterial calcification in dialysis: results of the double-blind, randomized, placebo-controlled RenaKvit trial.
Levy-Schousboe K; Frimodt-Møller M; Hansen D; Peters CD; Kjærgaard KD; Jensen JD; Strandhave C; Elming H; Larsen CT; Sandstrøm H; Brasen CL; Schmedes A; Madsen JS; Jørgensen NR; Frøkjær JB; Frandsen NE; Petersen I; Marckmann P
Clin Kidney J; 2021 Sep; 14(9):2114-2123. PubMed ID: 34476095
[TBL] [Abstract][Full Text] [Related]
10. The effect of menaquinone-7 supplementation on circulating species of matrix Gla protein.
Dalmeijer GW; van der Schouw YT; Magdeleyns E; Ahmed N; Vermeer C; Beulens JW
Atherosclerosis; 2012 Dec; 225(2):397-402. PubMed ID: 23062766
[TBL] [Abstract][Full Text] [Related]
11. Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial.
Diederichsen ACP; Lindholt JS; Möller S; Øvrehus KA; Auscher S; Lambrechtsen J; Hosbond SE; Alan DH; Urbonaviciene G; Becker SW; Fredgart MH; Hasific S; Folkestad L; Gerke O; Rasmussen LM; Møller JE; Mickley H; Dahl JS
Circulation; 2022 May; 145(18):1387-1397. PubMed ID: 35465686
[TBL] [Abstract][Full Text] [Related]
12. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial.
Knapen MH; Braam LA; Drummen NE; Bekers O; Hoeks AP; Vermeer C
Thromb Haemost; 2015 May; 113(5):1135-44. PubMed ID: 25694037
[TBL] [Abstract][Full Text] [Related]
13. Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial.
Westenfeld R; Krueger T; Schlieper G; Cranenburg EC; Magdeleyns EJ; Heidenreich S; Holzmann S; Vermeer C; Jahnen-Dechent W; Ketteler M; Floege J; Schurgers LJ
Am J Kidney Dis; 2012 Feb; 59(2):186-95. PubMed ID: 22169620
[TBL] [Abstract][Full Text] [Related]
14. Six months vitamin K treatment does not affect systemic arterial calcification or bone mineral density in diabetes mellitus 2.
Bartstra JW; Draaisma F; Zwakenberg SR; Lessmann N; Wolterink JM; van der Schouw YT; de Jong PA; Beulens JWJ
Eur J Nutr; 2021 Apr; 60(3):1691-1699. PubMed ID: 33068157
[TBL] [Abstract][Full Text] [Related]
15. High-Dose Menaquinone-7 Supplementation Reduces Cardiovascular Calcification in a Murine Model of Extraosseous Calcification.
Scheiber D; Veulemans V; Horn P; Chatrou ML; Potthoff SA; Kelm M; Schurgers LJ; Westenfeld R
Nutrients; 2015 Aug; 7(8):6991-7011. PubMed ID: 26295257
[TBL] [Abstract][Full Text] [Related]
16. Effect of vitamin K2 on progression of atherosclerosis and vascular calcification in nondialyzed patients with chronic kidney disease stages 3-5.
Kurnatowska I; Grzelak P; Masajtis-Zagajewska A; Kaczmarska M; Stefańczyk L; Vermeer C; Maresz K; Nowicki M
Pol Arch Med Wewn; 2015; 125(9):631-40. PubMed ID: 26176325
[TBL] [Abstract][Full Text] [Related]
17. High Dephosphorylated-Uncarboxylated MGP in Hemodialysis patients: risk factors and response to vitamin K
Aoun M; Makki M; Azar H; Matta H; Chelala DN
BMC Nephrol; 2017 Jun; 18(1):191. PubMed ID: 28592319
[TBL] [Abstract][Full Text] [Related]
18. Vitamin K supplementation and bone mineral density in dialysis: results of the double-blind, randomized, placebo-controlled RenaKvit trial.
Levy-Schousboe K; Marckmann P; Frimodt-Møller M; Peters CD; Kjærgaard KD; Jensen JD; Strandhave C; Sandstrøm H; Hitz MF; Langdahl B; Vestergaard P; Brasen CL; Schmedes A; Madsen JS; Jørgensen NR; Frøkjær JB; Frandsen NE; Petersen I; Hansen D
Nephrol Dial Transplant; 2023 Sep; 38(10):2131-2142. PubMed ID: 36460034
[TBL] [Abstract][Full Text] [Related]
19. The effect of Vitamin-K
Bellinge JW; Francis RJ; Lee SC; Vickery A; Macdonald W; Gan SK; Chew GT; Phillips M; Lewis JR; Watts GF; Schultz CJ
J Nucl Cardiol; 2022 Aug; 29(4):1855-1866. PubMed ID: 33825140
[TBL] [Abstract][Full Text] [Related]
20. No Detectable Coagulation Activation After Vitamin K (MK-7) Supplementation in Patients on Dialysis With Functional Vitamin K Deficiency: A One-Year Randomized, Placebo-Controlled Study.
Bladbjerg EM; Levy-Schousboe K; Frimodt-Møller M; Kjærgaard KD; Strandhave C; Brasen CL; Frandsen NE; Hansen D; Marckmann P
J Ren Nutr; 2024 Jul; 34(4):337-342. PubMed ID: 38128853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
